Novadip Biosciences
Belgium - Mont-Saint-GuibertBiotechnology
Focus: Novadip Biosciences is a Belgium-based biotechnology company founded in 2022 specializing in personalized, stem-cell based regenerative medicine. The company is in early-stage development with no commercial products or disclosed pipeline programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Novadip Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Novadip Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NVD-003, an autologous 3D scaffold free osteogenic graft
Congenital Pseudarthrosis of TibiaClinical Trials (1)
NCT05693558NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
Phase 1Help build intelligence for Novadip Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.